Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,760 | N/A | N/A | N/A | N/A |
| Marketable Securities | 53,074 | N/A | N/A | N/A | N/A |
| Receivables | 1,679 | N/A | N/A | N/A | N/A |
| Inventories | 6,729 | N/A | N/A | N/A | N/A |
| Other current assets | 6,662 | 0 | 0 | 0 | 0 |
| TOTAL | $112,322 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,776 | N/A | N/A | N/A | N/A |
| Intangibles | 46,880 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13,227 | 0 | 0 | 0 | 0 |
| TOTAL | $61,883 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $174,205 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,440 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 8,024 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 5,667 | N/A | N/A | N/A | N/A |
| Other current liabilities | 45,732 | N/A | N/A | N/A | N/A |
| TOTAL | $70,842 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,277 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 1,336 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 77,191 | 0 | 0 | 0 | 0 |
| TOTAL | $78,468 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $149,310 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 6,188 | N/A | N/A | N/A | N/A |
| Retained earnings | -320,452 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | -7,423 | 0 | 0 | 0 | 0 |
| TOTAL | $24,895 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $174,205 | $0 | $0 | $0 | $0 |